Clinicopathologic variable | HR (95% CI) | p-value |
---|---|---|
a | ||
Age (continuous) | 1.03 (1.02–1.05) | 0.000 *** |
BAG1 expression (Low vs. High) | 2.11 (1.5–2.97) | 0.000 *** |
Grade | 2.25 (1.83–2.77) | 0.000 *** |
Stage | 1.94 (1.72–2.22) | 0.000 *** |
Cancer Status (tumor free vs. with tumor) | 4.92 (3.52–6.91) | 0.000 *** |
Tumor size | 1.90 (1.61–2.31) | 0.000 *** |
Lymph nodes (positive vs. negative) | 3.41 (1.69–6.90) | 0.000 *** |
Distant metastasis (positive vs. negative) | 4.43 (3.18–6.61) | 0.000 *** |
Gender (male vs. Female) | 0.91 (0.65–1.31) | 0.576 |
hemoglobin result (Low vs. Normal) | 0.45 (0.30–0.66) | 0.000 *** |
history of neoadjuvant treatment (Yes vs. No) | 2.37 (1.21–4.66) | 0.012 * |
Serum calcium (Low vs. High) | 1.21 (0.81–1.61) | 0.431 |
b | ||
Tumor size | 1.25 (0.72–2.17) | 0.417 |
Lymph nodes (positive vs. negative) | 1.71 (0.78–3.73) | 0.175 |
Distant metastasis (positive vs. negative) | 1.97 (0.79–4.91) | 0.145 |
Stage | 1.25 (0.67–2.32) | 0.478 |
BAG1 expression (Low vs. High) | 1.75 (1.05–2.90) | 0.029* |